Eris Biotech
Y Combinator
ONCOLOGY
DRUG-DISCOVERY
BIOTECH
THERAPEUTICS
Current Round
Pre Seed
About
Our drugs engage the immune system to fight tumors
Prediction Markets
Would Eris Biotech get next round of funding before end of 2025?
64% YES
Closes: Dec. 31, 2025
Would Eris Biotech have an exit before end of 2030?
38% YES
Closes: Dec. 31, 2030